SCHEMBL19784586

SCHEMBL19784586

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)[nH]c3c5ccccc5c5oc6ccccc6c5c43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.35
▸ MAP3K11 Q16584 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAP3K9 P80192 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ CSNK1D P48730 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28452973 0.83 CDK4 (0.44) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL17451755 0.82 GABRP (0.44) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL22011594 0.81 MEN1 (0.41) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL16310389 0.80 CDK4 (0.42) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL25557421 0.80 ALDH1A1 (0.42) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL22078743 0.79 ALDH1A1 (0.43) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL21019591 0.79 ALDH1A1 (0.39) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL21019590 0.79 ALDH1A1 (0.39) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL21019363 0.79 ALDH1A1 (0.39) MAPTKMT2AMEN1CSF1RPDGFRB
SCHEMBL15127073 0.79 KDM4E (0.48) MAPTKMT2AMEN1CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-27 — — US disclosed
US-20190229271-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT DUK SAN NEOLUX CO., LTD. (KR) 2019-07-25 — — US disclosed
WO-2018012780-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT 덕산네오룩스 주식회사 2018-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF ESR1, GPX1, LEF1 MAPT 1456/4885KMT2A 1921/4885MEN1 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback